Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4    Pharmaceuticals 5       - Generics  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   A ACE Inhibitor Intolerance: A major driver of growth for the Aiirbs static version printer friendly Actavis IMS Company Profile static version printer friendly pdf version Algorithms for Visual Design Using the Processing Language static version printer friendly pdf version An Exploration of Consolidation in the Generics Industry static version printer friendly pdf version Anti-hypertensives: Patent Defense Strategies - Combating Generic Comp... static version printer friendly Apotex Generics Company Intelligence Report static version printer friendly pdf version Asia-Pacific Generics static version printer friendly Authorized Generics: Look Before you Leap static version printer friendly pdf version ^ Top B Barr: PharmaVitae Generics Profile static version printer friendly pdf version Bayesian Analysis of Gene Expression Data static version printer friendly pdf version Biogenerics: Challenges and Promise static version printer friendly Biosimilars (2009 - 2014) static version printer friendly pdf version Biosimilars: A Viable Market - But When? static version printer friendly pdf version Booming US Generic Drug Market static version printer friendly pdf version Business Strategies for Different Types of Biogenerics static version printer friendly pdf version ^ Top C Cap-Analysis Gene Expression (CAGE): The Science of Decoding Gene Tran... static version printer friendly pdf version CNS Generic Drugs: Prospects and Opportunities to 2012 static version printer friendly pdf version CNS Year in Review: 2001 static version printer friendly Combating Generics: Counter-Generics Strategy, Tactics and Execution static version printer friendly pdf version Commercial Insight: Antibacterials - Regulations, Resistance & Generic... static version printer friendly pdf version Commercial Insight: Migraine - Opportunities will Exist in the Wake of... static version printer friendly pdf version Competitor Analysis: Biogenerics & Therapeutic Proteins static version printer friendly pdf version Competitor Analysis: Human Growth Hormone (hGH) static version printer friendly pdf version Current Cardiovascular and Diabetes Blockbusters - Brands at Risk Bewa... static version printer friendly ^ Top D Drug Delivery 2000: A Key Company and Market Analysis static version printer friendly Drugs of Tommorrow 2002: Pain static version printer friendly pdf version Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly ^ Top E Emerging Blockbusters: 2009's Most Promising Drugs and the Future of t... static version printer friendly pdf version Emerging Generic Drug Companies Worldwide 2007 static version printer friendly pdf version Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version European Generic Gastrointestinal Pharmaceutical Markets static version printer friendly pdf version European Generics static version printer friendly ^ Top F Follow-On Products as a Defense Against Generics static version printer friendly Front-End Strategies to Meet Generics Challenges and Reduce Pharmaceut... static version printer friendly pdf version Future Growth Opportunities in Generics: The Impact of Consolidation o... static version printer friendly pdf version ^ Top G Generic Benchmarking: Brand Erosion at Patent Expiry static version printer friendly pdf version Generic Drug Market in Canada static version printer friendly pdf version Generic Drug Share of Total Market, 1984-2020 static version printer friendly pdf version Generic Pharmaceuticals in Belgium: A Strategic Reference, 2006 static version printer friendly pdf version Generic Series: An Introduction To The Canadian Generics Market - Key ... static version printer friendly pdf version Generic Strategies in Emerging Markets static version printer friendly pdf version Generics Defense Strategies: Effective Brand Protection through Patent... static version printer friendly Generics Erosion Patterns in the U.S. Market static version printer friendly pdf version Generics in Asia-Pacific static version printer friendly Generics in Belgium static version printer friendly Generics in Canada static version printer friendly Generics in China static version printer friendly Generics in Europe static version printer friendly Generics in France static version printer friendly Generics in Germany static version printer friendly Generics in Italy static version printer friendly Generics in Japan static version printer friendly Generics in Spain static version printer friendly Generics in the Animal Health Industry static version printer friendly pdf version Generics in the Netherlands static version printer friendly Generics in the United Kingdom static version printer friendly Generics in the United States static version printer friendly Generics Review 2000/ 2001 static version printer friendly Generics Series: Generics Trends in the Seven Major Markets and Beyond... static version printer friendly pdf version Generics Substitution in the Spotlight static version printer friendly Generics will Play an Increasingly Important Role in the Pharma Indust... static version printer friendly pdf version Generics: Global Industry Guide static version printer friendly Global Generics static version printer friendly Global Generics static version printer friendly Global Generics Guide 3rd Edition: Benchmarking Generics Company Capab... static version printer friendly pdf version Global Generics Guide: Benchmarking the Key Players static version printer friendly Global Generics Guide: Capitalizing On an $82 Billion Opportunity static version printer friendly Global Generics Guide: Part 2 - Benchmarking Country Markets and Strat... static version printer friendly Global Generics Industry Report static version printer friendly pdf version Global Healthcare Review - October 2002 static version printer friendly Global Healthcare Review - September 2002 static version printer friendly Growth Strategies In Generics: Innovative And Aggressive Strategies An... static version printer friendly ^ Top H Healthcare Review: Immune Disorders and Inflammation - September 2002 static version printer friendly Healthcare Review: Infectious Diseases - October 2002 static version printer friendly Healthcare Review: Licensing - October 2002 static version printer friendly pdf version Hormonal Contraception: Market Update - Surviving the Generic Threat static version printer friendly Human Growth Hormone - Delivery Technology Driving Market Growth static version printer friendly ^ Top I Impact of Generics on the Antidepressant Market static version printer friendly pdf version Indian Generics, 2008-2012: The Growing Threat to Westernised Markets static version printer friendly pdf version Indian Global Generics Market Size, 2003-2010 static version printer friendly pdf version Injectable Generic Drugs: Prospects and Opportunities to 2010 static version printer friendly ^ Top M Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy... static version printer friendly Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generi... static version printer friendly Market Dynamics 2001: Hormonals static version printer friendly Market Dynamics: HIV - Combating a Market Slowdown static version printer friendly pdf version Maximising the Drug Lifecycle static version printer friendly pdf version ^ Top N New Dynamics and Challenges in the Generics Market 2007 static version printer friendly pdf version ^ Top O Oomycete Genetics and Genomics: Diversity, Interactions and Research T... static version printer friendly pdf version Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil... static version printer friendly pdf version ^ Top P Partnering in the Global Generics Industry 2008: A Guide to Companies static version printer friendly pdf version Partnering in the Global Generics Industry 2009: A Guide to Companies static version printer friendly pdf version Pharaceutical Branding Strategies static version printer friendly pdf version Population Genetics and Microevolutionary Theory static version printer friendly pdf version Practical Defense Strategies for Combating Generics Competition static version printer friendly pdf version Pricing and Reimbursement Issues for Generics and Biosimilars static version printer friendly pdf version ^ Top R Reimbursement in Europe, Japan and the US: The Impact of Cost Shifting... static version printer friendly Retail Pharmacy Price Markups on Generic Drugs static version printer friendly pdf version ^ Top S Sandoz - PharmaVitae Generics Profile static version printer friendly pdf version Special Report: Patterns of Generic Erosion: An International Chartboo... static version printer friendly pdf version Strategic Intelligence: The Top 12 Pharmaceutical Companies static version printer friendly Strategic Perspectives 2001: Portfolio Management in the Anti-Fungal M... static version printer friendly Strategic Perspectives: Allergic Rhinitis - Impact of a blockbuster go... static version printer friendly pdf version Strategic Perspectives: Impact of the Cancer Generics Market static version printer friendly ^ Top T The Anemia Market: Biogenerics and Second-Generation Products Drive Ch... static version printer friendly pdf version The Biogenerics Market Outlook: An Analysis of Market Dynamics, Growth... static version printer friendly The Blockbuster Drugs Outlook: Optimum management strategies throughou... static version printer friendly pdf version The European Generics Outlook: A Country-By-Country Analysis Of Develo... static version printer friendly The Generics Industry in 2005: A New Threat to Pharma static version printer friendly The Generics Outlook 2001 static version printer friendly The Indian Pharmaceutical Industry 2009: Diversification, Expansion & ... static version printer friendly pdf version The Latin American Market for Generic Drugs - A Comparative Study of 7... static version printer friendly pdf version The Pharmaceuticals Industry Market Review static version printer friendly The Top 10 Generics Companies: Strategic Insight, Growth Opportunities... static version printer friendly pdf version The Top 20 Eastern European Manufacturers Of Generic Pharmaceuticals static version printer friendly pdf version The Top 60 European Manufacturers Of Generic Pharmaceuticals static version printer friendly pdf version Therapeutic Proteins: Strategic Market Analysis and Forecasts to 2010 static version printer friendly Toward a Biogenerics Market: The Regulatory Conundrum static version printer friendly pdf version ^ Top U U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Al... static version printer friendly U.S. Generic Pharmaceuticals Outlook static version printer friendly pdf version US and European Prescription Generic Markets: An Examination of Commer... static version printer friendly ^ Top W World Generic Drug Markets: Competitive Benchmarking static version printer friendly pdf version World Generic Market Report 2009 static version printer friendly pdf version World Generics and Biogenerics Markets static version printer friendly pdf version All rights reserved. © copyright 2008 Research and Markets Terms and conditions Privacy Policy